{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:28:53Z","timestamp":1788776933479,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajem.2021.12.039","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T02:22:27Z","timestamp":1640139747000},"page":"212-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Prospective real-time evaluation of the QTc interval variation after low-dose droperidol among emergency department patients"],"prefix":"10.1016","volume":"52","author":[{"given":"Luis","family":"Hern\u00e1ndez-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Bellolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia E.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"VanMeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Grush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Oliveira J. e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajem.2021.12.039_bb0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0736-4679(03)00044-1","article-title":"Droperidol in the emergency department: is it safe?","volume":"24","author":"Richards","year":"2003","journal-title":"J Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2021.12.039_bb0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1553-2712.2002.tb02301.x","article-title":"Droperidol\u2014behind the black box warning","volume":"9","author":"Horowitz","year":"2002","journal-title":"Acad Emerg Med"},{"issue":"11","key":"10.1016\/j.ajem.2021.12.039_bb0015","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2146\/ajhp060505","article-title":"Evidence-based review of the black-box warning for droperidol","volume":"64","author":"Jackson","year":"2007","journal-title":"Am J Heal Pharm"},{"issue":"1","key":"10.1016\/j.ajem.2021.12.039_bb0020","first-page":"3","article-title":"The effects of the FDA warning on the use of droperidol by U.S. emergency physicians","volume":"4","author":"Richards","year":"2003","journal-title":"Calif J Emerg Med"},{"issue":"5","key":"10.1016\/j.ajem.2021.12.039_bb0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1213\/00000539-199411000-00028","article-title":"Droperidol causes a dose-dependent prolongation of the QT interval","volume":"79","author":"Lischke","year":"1994","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.ajem.2021.12.039_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ajem.2003.09.003","article-title":"Unexpected cardiovascular deaths are rare with therapeutic doses of droperidol","volume":"22","author":"Mullins","year":"2004","journal-title":"Am J Emerg Med"},{"issue":"22","key":"10.1016\/j.ajem.2021.12.039_bb0035","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/ajhp\/zxaa271","article-title":"Reintegrating droperidol into emergency medicine practice","volume":"77","author":"Mattson","year":"2020","journal-title":"Am J Heal Pharm"},{"issue":"7","key":"10.1016\/j.ajem.2021.12.039_bb0040","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ajem.2019.09.007","article-title":"Effectiveness and safety of droperidol in a United States emergency department","volume":"38","author":"Gaw","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2021.12.039_bb0045","doi-asserted-by":"crossref","first-page":"728","DOI":"10.5811\/westjem.2020.4.47036","article-title":"The incidence of QT prolongation and torsades des pointes in patients receiving droperidol in an urban emergency department","volume":"21","author":"Cole","year":"2020","journal-title":"West J Emerg Med"},{"issue":"7","key":"10.1016\/j.ajem.2021.12.039_bb0050","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ajem.2011.08.010","article-title":"Treating primary headaches in the ED: can droperidol regain its role?","volume":"30","author":"Faine","year":"2012","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2021.12.039_bb0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/PEC.0b013e3181d6d9f2","article-title":"Droperidol use in pediatric emergency department patients","volume":"26","author":"Szwak","year":"2010","journal-title":"Pediatr Emerg Care"},{"issue":"4","key":"10.1016\/j.ajem.2021.12.039_bb0060","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.annemergmed.2010.05.037","article-title":"Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study","volume":"56","author":"Isbister","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2021.12.039_bb0065","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1553-2712.2008.00197.x","article-title":"Olanzapine versus droperidol for the treatment of primary headache in the emergency department","volume":"15","author":"Hill","year":"2008","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2021.12.039_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","article-title":"Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department","volume":"47","author":"Knott","year":"2006","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.12.039_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajem.2005.08.017","article-title":"Antiemetics in the ED: a randomized controlled trial comparing 3 common agents","volume":"24","author":"Braude","year":"2006","journal-title":"Am J Emerg Med"},{"issue":"12","key":"10.1016\/j.ajem.2021.12.039_bb0080","first-page":"1167","article-title":"Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam","volume":"12","author":"Martel","year":"2005","journal-title":"Acad Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.12.039_bb0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jemermed.2003.05.005","article-title":"Droperidol vs. prochlorperazine for the treatment of acute headache","volume":"26","author":"Weaver","year":"2004","journal-title":"J Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.12.039_bb0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.WNL.0000042477.63516.B2","article-title":"Acute migraine treatment with droperidol","volume":"60","author":"Silberstein","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ajem.2021.12.039_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/ajem.2002.30007","article-title":"A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache","volume":"20","author":"Richman","year":"2002","journal-title":"Am J Emerg Med"},{"issue":"8","key":"10.1016\/j.ajem.2021.12.039_bb0100","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/acem.13650","article-title":"Randomized placebo-controlled trial of droperidol and ondansetron for adult emergency department patients with nausea","volume":"26","author":"Meek","year":"2019","journal-title":"Acad Emerg Med"},{"issue":"12","key":"10.1016\/j.ajem.2021.12.039_bb0105","first-page":"1402","article-title":"A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population","volume":"9","author":"Chase","year":"2002","journal-title":"Acad Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2021.12.039_bb0110","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1197\/aemj.9.6.650","article-title":"Intramuscular droperidol versus intramuscular dimenhydrinate for the treatment of acute peripheral Vertigo in the emergency department: a randomized clinical trial","volume":"9","author":"Irving","year":"2002","journal-title":"Acad Emerg Med"},{"issue":"5","key":"10.1016\/j.ajem.2021.12.039_bb0115","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jemermed.2018.12.036","article-title":"Rescue sedation when treating acute agitation in the emergency department with intramuscular antipsychotics","volume":"56","author":"Klein","year":"2019","journal-title":"J Emerg Med"},{"issue":"7","key":"10.1016\/j.ajem.2021.12.039_bb0120","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/add.13780","article-title":"Intravenous midazolam\u2013droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial","volume":"112","author":"Yap","year":"2017","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.ajem.2021.12.039_bb0125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annemergmed.2016.07.033","article-title":"Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial","volume":"69","author":"Taylor","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2021.12.039_bb0130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.annemergmed.2015.03.016","article-title":"The safety and effectiveness of droperidol for sedation of acute behavioral disturbance in the emergency department","volume":"66","author":"Calver","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2021.12.039_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1192\/bjp.bp.114.150227","article-title":"Droperidol v. haloperidol for sedation of aggressive behaviour in acute mental health: randomised controlled trial","volume":"206","author":"Calver","year":"2015","journal-title":"Br J Psychiatry"},{"issue":"5","key":"10.1016\/j.ajem.2021.12.039_bb0140","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bcp.12272","article-title":"High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings","volume":"77","author":"Calver","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ajem.2021.12.039_bb0145","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ajem.2013.03.026","article-title":"Parenteral sedation of elderly patients with acute behavioral disturbance in the ED","volume":"31","author":"Calver","year":"2013","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2021.12.039_bb0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jemermed.2014.12.024","article-title":"American academy of emergency medicine position statement: safety of droperidol use in the emergency department","volume":"49","author":"Perkins","year":"2015","journal-title":"J Emerg Med"},{"issue":"8","key":"10.1016\/j.ajem.2021.12.039_bb0155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"Von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajem.2021.12.039_bb0160","first-page":"353","article-title":"An analysis of the time-relations of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1016\/j.ajem.2021.12.039_bb0165","author":"Bazett formula"},{"issue":"4","key":"10.1016\/j.ajem.2021.12.039_bb0170","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mem.2003.110","article-title":"Droperidol, QT prolongation, and sudden death: what is the evidence?","volume":"41","author":"Kao","year":"2003","journal-title":"Ann Emerg Med"},{"issue":"7","key":"10.1016\/j.ajem.2021.12.039_bb0175","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.gie.2006.01.052","article-title":"Droperidol, when used for sedation during ERCP, may prolong the QT interval","volume":"63","author":"Yimcharoen","year":"2006","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.ajem.2021.12.039_bb0180","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00000542-200506000-00007","article-title":"Effect of low-dose droperidol on the QT interval during and after general anesthesiaa placebo-controlled study","volume":"102","author":"White","year":"2005","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.ajem.2021.12.039_bb0185","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/bcp.12527","article-title":"Small doses of droperidol do not present relevant torsadogenic actions: a double-blind, ondansetron-controlled study","volume":"79","author":"Tracz","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ajem.2021.12.039_bb0190","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","article-title":"Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron","volume":"102","author":"Charbit","year":"2005","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.ajem.2021.12.039_bb0195","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.anes.0000281893.39781.64","article-title":"Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?","volume":"107","author":"Nuttall","year":"2007","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.ajem.2021.12.039_bb0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/ALN.0b013e31827dde8d","article-title":"Does low-dose droperidol increase the risk of polymorphic ventricular tachycardia or death in the surgical patient?","volume":"118","author":"Nuttall","year":"2013","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.ajem.2021.12.039_bb0205","article-title":"Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis","volume":"19","author":"Weibel","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ajem.2021.12.039_bb0210","article-title":"Which QT correction formulae to use for QT monitoring?","volume":"5","author":"Vandenberk","year":"2016","journal-title":"J Am Hear Assoc Cardiovasc Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.ajem.2021.12.039_bb0215","first-page":"1","article-title":"Effect of serum electrolytes within normal ranges on QTc prolongation: a cross-sectional study in a Chinese rural general population","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Cardiovasc Disord 2018 181"},{"key":"10.1016\/j.ajem.2021.12.039_bb0220","author":"Hawthorne effect"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572101010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572101010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:58:06Z","timestamp":1760025486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073567572101010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":44,"alternative-id":["S073567572101010X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.12.039","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective real-time evaluation of the QTc interval variation after low-dose droperidol among emergency department patients","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}